1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
66073E482657FB44D852575F90033DABD
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/db-formulary-list-placement-winning-practices-for-managed-care-organizations
18
19
2054.174.51.80
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Managed Care Effective Pull-Through Marketing

Formulary List Placement: Winning Practices for Managed Care Organizations

ID: 5052


Features:

15 Info Graphics

20 Data Graphics

150 Metrics


Pages/Slides: 60


Published: Pre-2014


Delivery Format: Online PDF Document


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

 


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • STUDY SNAPSHOT
  • SPECIAL OFFER
In today's pharmaceutical marketplace, companies not only have to fight to win product placement on Managed Care formularies but also to "pull through" the business and increase market share after a formulary win. To benefit from formulary wins, savvy companies ensure that their sales forces and account management teams have the necessary skills and tools to pull-through demand for the favored products and increase sales.


This Best Practices, LLC research investigates pull-through challenges and the best practices that companies have developed to overcome them. The research will enable pharmaceutical, bio-pharma and medical device company leadership to identify program gaps, uncover insights and discover successful best practices to share with their employees.


Industries Profiled:
Pharmaceutical; Medical Device; Biotech; Consumer Products; Diagnostic; Health Care; Research


Companies Profiled:
Abbott Laboratories; Alcon; Allergan; AstraZeneca; Bayer Healthcare; Boehringer Ingelheim; Daiichi Sankyo; Galderma; GlaxoSmithKline; Johnson & Johnson; Merck; Novo Nordisk; PerkinElmer; Pfizer; Sanofi-Aventis; Solvay Pharmaceuticals; Smith & Nephew; Takeda Pharmaceuticals; Tibotec-Virco; Upsher-Smith; Xanodyne Pharmaceuticals; Taro; Caldera


Study Snapshot

The research involved an online survey of 33 Managed Care and Sales leaders at 24 leading pharmaceutical, biotechnology and medical device companies. In addition, Best Practices, LLC, analysts conducted in-depth interviews with respondents from five participating companies to collect executive insights and harvest best practices on achieving pull-through.

Key topics include:
  • Pull-through program types
  • Targeted customer groups
  • Program leadership
  • Process excellence in pull-through
  • Training
  • Tools & templates used
  • Education topics for healthcare providers
  • Education topics for patients
  • Education channels & media
  • KOL management in pull-through
  • Pull-through effectiveness metrics and measurement
  • Resource levels for pull-through
  • Top challenges
  • Best practices

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.